Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow ILMN
Illumina, Inc. (ILMN) Operating margin
Illumina, Inc.'s operating margin over the twelve months to 30 June 2026 was 19.7%, up 1.1 percentage points from fiscal 2025 (18.6%). Over the past ten years it has ranged from −91.2% (fiscal 2022) to 27.8% (fiscal 2019); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 18.6% | 37.63 |
| FY2024 | −19.1% | 4.68 |
| FY2023 | −23.7% | 67.43 |
| FY2022 | −91.2% | (88.44) |
| FY2021 | −2.72% | (20.63) |
| FY2020 | 17.9% | (9.89) |
| FY2019 | 27.8% | 1.31 |
| FY2018 | 26.5% | 4.47 |
| FY2017 | 22.0% | (2.46) |
| FY2016 | 24.5% | (3.13) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 21.1% | 1.98 |
| Mar 2026 | 19.2% | 1.73 |
| Dec 2025 | 17.4% | (3.51) |
| Sep 2025 | 20.9% | 0.73 |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 32.0% |
| MTD Mettler-Toledo International, Inc. compare | 28.4% |
| A Agilent Technologies, Inc. compare | 22.2% |
| ILMN Illumina, Inc. | 19.7% |
| DGX Quest Diagnostics Incorporated compare | 14.1% |
| IQV IQVIA Holdings Inc. compare | 13.0% |
| LH Labcorp Holdings Inc. compare | 10.4% |
| WAT Waters Corporation compare | 7.10% |
| NTRA Natera, Inc. compare | −10.7% |
| Diagnostics & Research industry median | −8.57% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement